Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Calgary

$86,520.00

Development of a Novel Iron-Based Supplement for Athletes

EF 2023-24

Résumé
Iron is an essential component of oxygen transport and energy production in humans. It is a critically important micronutrient for sport and exercise performance, especially in female athletes. In female athletes, menstruation combined with exercise-induced losses makes the problem particularly acute with sub-optimal iron levels affecting up to 50% of endurance athletes. At present, diet and iron supplementation strategies are often insufficient to correct the problem due to low iron absorption and side effects including gastrointestinal upset. To remedy this, we are developing and testing the efficacy of a novel iron supplement (FeSC) in collaboration with our industry partners, Lallemand Bio Ingredients (QC) and Nimble Science (AB). Highly advanced and patented technologies developed by Lallemand Bio-Ingredients allows iron to be complexed to a nutritional yeast. Once bound, the yeast is pasteurized, inactivating any live yeast. The resulting product will be tested pre- and post- supplementation in female athletes. Outcomes will include measures of iron status, hemoglobin mass, blood volume, quality of life and performance-based outcomes. To understand the mechanisms of supplement action, upper (Nimble Science, SIMBA sampling device) and lower gastrointestinal microbiota samples will be obtained. Complementary measures include untargeted serum metabolomics and metallomics. This 2-year research program will combine technological innovations in supplement manufacturing, a novel gut-based sampling device and a diverse team of nutrition experts to evaluate product efficacy. In collaboration with MITACS partnerships, highly qualified personnel will be positioned to take on leadership roles within academia, government, and industry. The university-industry synergies in this partnership will drive innovation that will yield scientific advancements in our understanding of a novel form of iron administration. Results have the potential to mitigate sub-optimal iron levels in female athletes and will support the future innovation, development and growth of other yeast complexed supplements for Canadians.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
586408-2023
Name nom
Shearer, Jane J
Department département
Kinesiology, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
86520
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
6103
Research subject group en
Food science and technology
Research subject group fr
Food processing, packaging, preservation and storage
Research subject en
Science et technologie de l'alimentation
Research subject fr
Transformation, conditionnement, conservation et stockage des aliments
Application title
Development of a Novel Iron-Based Supplement for Athletes
Keyword
Biochemistry; Blood Volume; Fiber; Metabolism; Metabolomics; Metal; Microbiota; Nutrition; Performance; Trace Ion
Application summary
Iron is an essential component of oxygen transport and energy production in humans. It is a critically important micronutrient for sport and exercise performance, especially in female athletes. In female athletes, menstruation combined with exercise-induced losses makes the problem particularly acute with sub-optimal iron levels affecting up to 50% of endurance athletes. At present, diet and iron supplementation strategies are often insufficient to correct the problem due to low iron absorption and side effects including gastrointestinal upset. To remedy this, we are developing and testing the efficacy of a novel iron supplement (FeSC) in collaboration with our industry partners, Lallemand Bio Ingredients (QC) and Nimble Science (AB). Highly advanced and patented technologies developed by Lallemand Bio-Ingredients allows iron to be complexed to a nutritional yeast. Once bound, the yeast is pasteurized, inactivating any live yeast. The resulting product will be tested pre- and post- supplementation in female athletes. Outcomes will include measures of iron status, hemoglobin mass, blood volume, quality of life and performance-based outcomes. To understand the mechanisms of supplement action, upper (Nimble Science, SIMBA sampling device) and lower gastrointestinal microbiota samples will be obtained. Complementary measures include untargeted serum metabolomics and metallomics. This 2-year research program will combine technological innovations in supplement manufacturing, a novel gut-based sampling device and a diverse team of nutrition experts to evaluate product efficacy. In collaboration with MITACS partnerships, highly qualified personnel will be positioned to take on leadership roles within academia, government, and industry. The university-industry synergies in this partnership will drive innovation that will yield scientific advancements in our understanding of a novel form of iron administration. Results have the potential to mitigate sub-optimal iron levels in female athletes and will support the future innovation, development and growth of other yeast complexed supplements for Canadians.